Bioanalytical Systems (NASDAQ:BASI) will post its quarterly earnings results before the market opens on Monday, February 12th.
Shares of Bioanalytical Systems (NASDAQ BASI) opened at $1.96 on Monday. The stock has a market capitalization of $16.16, a price-to-earnings ratio of -11.53 and a beta of 0.94. Bioanalytical Systems has a 1-year low of $0.81 and a 1-year high of $2.95. The company has a quick ratio of 0.57, a current ratio of 0.69 and a debt-to-equity ratio of 0.57.
An institutional investor recently raised its position in Bioanalytical Systems stock. Vanguard Group Inc. grew its holdings in Bioanalytical Systems, Inc. (NASDAQ:BASI) by 12.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 112,296 shares of the company’s stock after purchasing an additional 12,300 shares during the period. Vanguard Group Inc. owned approximately 1.37% of Bioanalytical Systems worth $190,000 as of its most recent SEC filing. Institutional investors own 5.14% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Bioanalytical Systems (BASI) Scheduled to Post Earnings on Monday” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/05/bioanalytical-systems-basi-scheduled-to-post-earnings-on-monday.html.
Bioanalytical Systems Company Profile
Bioanalytical systems, Inc is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies.
Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.